Skip to content

Contagious Salmon Anemia (ISA): Its Impact on Aquatic Life and Human Consumption of Seafood

Identifying Infectious Salmon Anaemia (ISA): Recognition Signs, Steps to Take if Suspected, and Strategies for Containment

Deadly Salmon Disease Known as Infectious Salmon Anaemia (ISA)
Deadly Salmon Disease Known as Infectious Salmon Anaemia (ISA)

Contagious Salmon Anemia (ISA): Its Impact on Aquatic Life and Human Consumption of Seafood

Preventing the Spread of Infectious Salmon Anemia (ISA): A Guide for Fish Farmers and Enthusiasts

Infectious Salmon Anemia (ISA) is a serious disease that primarily affects farmed Atlantic salmon, as well as rainbow trout and brown trout in seawater. This disease, which is spread through contact with infected fish, contaminated water, and equipment, can have devastating effects on fish populations and the aquaculture industry.

Under the Aquatic Animal Health (England and Wales) Regulations 2009, it is a legal obligation to report any suspicion or knowledge of ISA in farmed or wild fish to the Fish Health Inspectorate (FHI). Failure to do so is an offence under the regulations. The FHI can be contacted at [email protected] website, 01305 206700 (Monday to Thursday - 9:00 am to 5:00 pm, Friday 9:00 am to 4:30 pm), or 01305 206630 for emergencies out of hours. The Fish Health Inspectorate Centre is located at Barrack Road, The Nothe, Weymouth, Dorset, DT4 8UB.

The regulations also establish mandatory reporting requirements and control measures to prevent the spread of ISA. This includes the ability for authorities to impose movement restrictions on fish stocks, enforce biosecurity measures, and mandate the culling or destruction of infected or exposed fish to contain outbreaks. Regular surveillance programs are instituted to monitor the presence of ISA in aquaculture sites under these regulations. Control zones can be designated around infected sites, within which strict disinfection and management controls apply to limit disease spread.

Good husbandry and biosecurity practices, such as surface disinfection of newly fertilized and eyed salmonid eggs, are essential for protecting fish from ISA. It is important to ensure any fish introduced are ISA-free. Avoid purchasing fish of unknown origin and follow the rules on importing, exporting, and moving fish.

ISA can be spotted by signs such as lethargy, pale gills, swollen abdomen, bulging eyes, a dark and swollen spleen, and a dark liver. Infected fish do not have to be sick or diseased to spread the virus. If fish show signs of ISA, report it immediately to the FHI. The FHI will investigate and apply disease control measures if necessary.

While ISA does not affect humans, it can have significant economic and environmental impacts. It was first detected in Norway in the early 1980's and has since been found in Canada, Scotland, Faroe islands, USA, Chile, and the UK (3 outbreaks between 1998 and 2009). Great Britain is currently free from ISA, which is a 'listed' or 'notifiable' disease.

For more information on susceptible and vector species, as well as detailed guidance on biosecurity measures, plans, and templates, visit the FHI's website. The World Organisation for Animal Health (WOAH) also has a chapter on ISA.

By following these guidelines and remaining vigilant, we can help prevent and control the spread of ISA, safeguarding our aquatic animal health and the aquaculture industry.

Scientists and medical professionals in the field of health and wellness emphasize the importance of understanding Infectious Salmon Anemia (ISA), a serious disease that primarily affects farmed salmon and trout, due to its potential devastating effects on fish populations and the aquaculture industry. Regularly reporting any suspicion or knowledge of ISA to the Fish Health Inspectorate (FHI) is a crucial step in preventing its spread, as required by the Aquatic Animal Health Regulations.

Read also:

    Latest

    Customs and Border Protection (CBP) in collaboration with the Food and Drug Administration (FDA)...

    Customs and Border Protection (CBP) and Food and Drug Administration (FDA) collaboratively seized over $3.5 million worth of fake medications at Cincinnati port.

    During a seven-day collaborative endeavor by U.S. Customs and Border Protection and the U.S. Food and Drug Administration, CBP officers scrutinized numerous packages suspected of concealing counterfeit and unauthorized pharmaceuticals at the Port of Cincinnati. The examinations revealed an...